Loading clinical trials...
Loading clinical trials...
PROSPECT-C: A Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Cetuximab or Panitumumab in Metastatic Colorectal Cancer
Conditions
Interventions
Cetuximab
Locations
1
United Kingdom
The Royal Marsden NHS Foundation Trust
Surrey, Sutton, United Kingdom
Start Date
November 1, 2012
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
December 19, 2016
NCT04657068
NCT06625775
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Royal Marsden NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions